Mouse Anti-IL19 Recombinant Antibody (A491) (CBMAB-AP10833LY)

Della Bella, C., Antico, A., Panozzo, M. P., Capitani, N., Benagiano, M., Petrone, L., ... & D’Elios, M. M. (2022). Elevated IL-19 serum levels in patients with pernicious anemia and autoimmune gastritis. Frontiers in Immunology, 13, 887256.

Chen, W., Xing, J., Liu, X., Wang, S., & Xing, D. (2021). The role and transformative potential of IL-19 in atherosclerosis. Cytokine & Growth Factor Reviews, 62, 70-82.

Azuma, Y. T., Fujita, T., Izawa, T., Hirota, K., Nishiyama, K., Ikegami, A., ... & Tsuneyama, K. (2021). Il-19 contributes to the development of nonalcoholic steatohepatitis by altering lipid metabolism. Cells, 10(12), 3513.

Dogan, M., Sahin, M., & Yenisey, C. (2019). Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp. European Archives of Oto-Rhino-Laryngology, 276, 1685-1691.

An, W., Yu, Y., Zhang, Y., Zhang, Z., Yu, Y., & Zhao, X. (2019). Exogenous IL‐19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction. British journal of pharmacology, 176(5), 699-710.

Weng, Y. H., Chen, W. Y., Lin, Y. L., Wang, J. Y., & Chang, M. S. (2019). Blocking IL-19 signaling ameliorates allergen-induced airway inflammation. Frontiers in Immunology, 10, 968.

Konrad, R. J., Higgs, R. E., Rodgers, G. H., Ming, W., Qian, Y. W., Bivi, N., ... & Nickoloff, B. J. (2019). Assessment and clinical relevance of serum IL-19 levels in psoriasis and atopic dermatitis using a sensitive and specific novel immunoassay. Scientific Reports, 9(1), 5211.

Ray, M., Gabunia, K., Vrakas, C. N., Herman, A. B., Kako, F., Kelemen, S. E., ... & Autieri, M. V. (2018). Genetic deletion of IL-19 (interleukin-19) exacerbates atherogenesis in Il19−/−× Ldlr−/− double knockout mice by dysregulation of mRNA stability protein HuR (human antigen R). Arteriosclerosis, thrombosis, and vascular biology, 38(6), 1297-1308.

Autieri, M. V. (2018). IL-19 and other IL-20 family member cytokines in vascular inflammatory diseases. Frontiers in Immunology, 9, 700.

Herman, A. B., Vrakas, C. N., Ray, M., Kelemen, S. E., Sweredoski, M. J., Moradian, A., ... & Autieri, M. V. (2018). FXR1 is an IL-19-responsive RNA-binding protein that destabilizes pro-inflammatory transcripts in vascular smooth muscle cells. Cell reports, 24(5), 1176-1189.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols